Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

311
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
311
Hybridoma Technology01:31

Hybridoma Technology

17.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.2K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

208
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
208
Antibody Actions01:26

Antibody Actions

2.3K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
2.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Pharmacological management of elevated LDL in patients with hypercholesterolemia and mixed dyslipidaemia.

Expert opinion on pharmacotherapy·2026
Same author

Lipoprotein(a) - treatments in development.

Expert opinion on pharmacotherapy·2025
Same author

Statin-Related Transaminitis-Is It Necessary to Stop Statins?

Cardiovascular drugs and therapy·2025
Same author

Options for patients with out-of-control blood pressure: after all avenues have been exhausted.

Expert review of cardiovascular therapy·2024
Same author

Advances in Dyslipidaemia Treatments: Focusing on ApoC3 and ANGPTL3 Inhibitors.

Journal of lipid and atherosclerosis·2024
Same author

Canagliflozin + metformin ER for the treatment of type 2 diabetes: the evidence to date.

Expert opinion on pharmacotherapy·2023

相关实验视频

Updated: Jan 12, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.5K

基于抗体的治疗方法用于高胆固醇血清症.

Brian Tomlinson1, Paul Chan2

  • 1Faculty of Medicine, Macau University of Science & Technology, Macau, 999078, People's Republic of China.

Biologics : targets & therapy
|November 3, 2025
PubMed
概括

针对PCSK9,ANGPTL3和ANGPTL4的单克隆抗体,在他类药物失败时为高胆固醇血症提供了新的治疗方法. 这些先进疗法可降低高危患者的LDL胆固醇和心血管风险.

科学领域:

  • 心血管医学 心血管医学
  • 药理学 药理学是指药理学的学科.
  • 生物技术是生物技术.

背景情况:

  • 类药物和ezetimibe是高胆固醇血症的第一线治疗方法,但往往不足以达到低密度脂蛋白 (LDL) 胆固醇的目标.
  • 尽管使用标准口服疗法,但LDL胆固醇不受控制的患者仍然存在残留心血管风险.

研究的目的:

  • 审查开发用于解决与不受控制的LDL胆固醇相关的残留心血管风险的单克隆抗体 (mAbs).
  • 讨论针对PCSK9,ANGPTL3和ANGPTL4的新型mAbs,用于高胆固醇血症的管理.

主要方法:

  • 关于用于高胆固醇血症治疗的单克隆抗体的科学文献的综述.
  • 对PCSK9,ANGPTL3和ANGPTL4抑制剂的疗效和安全数据的分析.

主要成果:

  • PCSK9抑制剂 (alirocumab,evolocumab) 对高风险患者有效且安全,但无法达到LDL目标.
  • 在中国批准的较新的PCSK9 mAbs提供较少的剂量.
  • 埃维纳库马布 (ANGPTL3 抑制剂) 已批准用于同卵性家族性高胆固醇血症;其他 ANGPTL3 和 ANGPTL4 mAbs 正在开发中.

结论:

关键词:
血管形成素类似的3动脉样硬化心血管疾病家庭性高胆固醇血症是什么?这是一种单克隆抗体.蛋白转化酶亚提利辛/凯类型9

更多相关视频

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

12.3K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

14.0K

相关实验视频

Last Updated: Jan 12, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.5K
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

12.3K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

14.0K
  • 单克隆抗体在治疗高胆固醇血症和降低心血管风险方面取得了重大进展.
  • 新兴的疗法,如反感性寡核酸和小干扰RNA,可能会提供更具成本效益的替代方案.
  • 需要进行进一步的研究,以确定新型mAbs.的长期疗效和更广泛的指示.